Subscribe
shutterstock_295193522_digital_deliverance
Digital Deliverance / Shutterstock.com
26 September 2019GenericsRory O'Neill

China awards generics contracts to lowest bidders

China’s drug pricing overhaul has seen the average cost of drugs drop by more than half (59%), the country’s Joint Procurement Office (JPO) announced this week.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
UK Labour promises public generics company, compulsory drug licensing
25 September 2019   Jeremy Corbyn, leader of the UK Labour Party, has pledged to create a publicly-owned drugs manufacturer and use compulsory licensing to sell generic, lower priced versions of drugs to the country’s National Health Service.
Big Pharma
US officials call for review of government-owned IP management
19 June 2019   A US congressman and senator have asked the country’s audit institution, the Government Accountability Office to review the management of government-owned IP in the health sector.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Europe
UK Labour promises public generics company, compulsory drug licensing
25 September 2019   Jeremy Corbyn, leader of the UK Labour Party, has pledged to create a publicly-owned drugs manufacturer and use compulsory licensing to sell generic, lower priced versions of drugs to the country’s National Health Service.
Big Pharma
US officials call for review of government-owned IP management
19 June 2019   A US congressman and senator have asked the country’s audit institution, the Government Accountability Office to review the management of government-owned IP in the health sector.

More on this story

Europe
UK Labour promises public generics company, compulsory drug licensing
25 September 2019   Jeremy Corbyn, leader of the UK Labour Party, has pledged to create a publicly-owned drugs manufacturer and use compulsory licensing to sell generic, lower priced versions of drugs to the country’s National Health Service.
Big Pharma
US officials call for review of government-owned IP management
19 June 2019   A US congressman and senator have asked the country’s audit institution, the Government Accountability Office to review the management of government-owned IP in the health sector.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB